MNM Diagnosticssp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-03-30
Share capital
61,250.00 PLN
Registered address
ul. Szelągowska 24, 61-626 Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2022, 243 days late), 2 not filed.

  • 202526/06/2026
  • 2024not filed
  • 2023not filed
  • 202214/03/2024
  • 202111/07/2022
  • 202007/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 14.24kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 9.49kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 4.74kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 237.22kMedianUSD 133.19kAverageUSD 3.03m

Trademarks

MNM Diagnostics holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2020.

MarkNumberClassesStatusProtected until
Polskie Centrum BiobankowaniaZ.51107042, 44Protected Mar 6, 2030
MarkProtected until
Polskie Centrum BiobankowaniaMar 6, 2030

Authorized Representatives

Marcin Błaszyk – Liquidator

Ownership

OwnerSharesShare valueStake
Mnm Diagnostics, Inc.
1,225$16,545.11100%

Beneficial owners

Person

Debt

2 active proceedings recorded in KRZ.

Registration dateProceeding typeStatus
Feb 3, 2025
Bankruptcy proceedings for an entrepreneur
In progress
Jul 14, 2023
Petition to declare entrepreneur bankruptcy
Closed

Public aid

7 public aid cases recorded, with a total value of $545,504.

PurposeGross amount
Aid for research and development projects: industrial research
$158K
Aid for research and development projects: experimental development
$124.5K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,600

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.
Relvosp. z o.o.
Microblicsp. z o.o.
Xenstatssp. z o.o.
InventroS.A.
Detoxedsp. z o.o.
Fungotechsp. z o.o.
Dystrogen TherapeuticsS.A.
MIMO BiotechP.S.A.

Change history

DateEvent
2025-02-18Name change
2023-07-25Address change
2023-07-25Name change
2023-05-29Liquidation opened
2020-04-09Share capital increase

FAQ

Last updated: 2026-07-10